These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36696954)

  • 1. New C-indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causes.
    Sheikh MT; Chen MH; Gelfond JA; Sun W; Ibrahim JG
    Stat Med; 2023 Apr; 42(9):1308-1322. PubMed ID: 36696954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint modelling of longitudinal and survival data in the presence of competing risks with applications to prostate cancer data.
    Sheikh MT; Ibrahim JG; Gelfond JA; Sun W; Chen MH
    Stat Modelling; 2021 Feb; 21(1-2):72-94. PubMed ID: 34177376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An issue of identifying longitudinal biomarkers for competing risks data with masked causes of failure considering frailties model.
    Ko FS
    Stat Methods Med Res; 2020 Feb; 29(2):603-616. PubMed ID: 30991892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data.
    Deslandes E; Chevret S
    BMC Med Res Methodol; 2010 Jul; 10():69. PubMed ID: 20670425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian inference of the fully specified subdistribution model for survival data with competing risks.
    Ge M; Chen MH
    Lifetime Data Anal; 2012 Jul; 18(3):339-63. PubMed ID: 22484596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A general joint model for longitudinal measurements and competing risks survival data with heterogeneous random effects.
    Huang X; Li G; Elashoff RM; Pan J
    Lifetime Data Anal; 2011 Jan; 17(1):80-100. PubMed ID: 20549344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partially linear mixed-effects joint models for skewed and missing longitudinal competing risks outcomes.
    Lu T; Lu M; Wang M; Zhang J; Dong GH; Xu Y
    J Biopharm Stat; 2019; 29(6):971-989. PubMed ID: 29252088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
    Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
    Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian nonparametric mixed-effects joint model for longitudinal-competing risks data analysis in presence of multiple data features.
    Lu T
    Stat Methods Med Res; 2017 Oct; 26(5):2407-2423. PubMed ID: 26265770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials.
    Zhang D; Chen MH; Ibrahim JG; Boye ME; Wang P; Shen W
    Stat Med; 2014 Nov; 33(27):4715-33. PubMed ID: 25044061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian approach to competing risks analysis with masked cause of death.
    Sen A; Banerjee M; Li Y; Noone AM
    Stat Med; 2010 Jul; 29(16):1681-95. PubMed ID: 20575048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint modeling of repeated multivariate cognitive measures and competing risks of dementia and death: a latent process and latent class approach.
    Proust-Lima C; Dartigues JF; Jacqmin-Gadda H
    Stat Med; 2016 Feb; 35(3):382-98. PubMed ID: 26376900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic prediction of competing risk events using landmark sub-distribution hazard model with multiple longitudinal biomarkers.
    Wu C; Li L; Li R
    Stat Methods Med Res; 2020 Nov; 29(11):3179-3191. PubMed ID: 32419611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A joint model for longitudinal measurements and survival data in the presence of multiple failure types.
    Elashoff RM; Li G; Li N
    Biometrics; 2008 Sep; 64(3):762-771. PubMed ID: 18162112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Importance of Biomarkers: a Bayesian Joint Modeling Approach of Longitudinal and Survival Data with Semicompeting Risks.
    Zhang F; Chen MH; Cong XJ; Chen Q
    Stat Modelling; 2021 Feb; 21(1-2):30-55. PubMed ID: 34326706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the NINDS rt-PA stroke trial.
    Li N; Elashoff RM; Li G; Saver J
    Stat Med; 2010 Feb; 29(5):546-57. PubMed ID: 19943331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence analysis for skew-normal semiparametric joint models of multivariate longitudinal and multivariate survival data.
    Tang AM; Tang NS; Zhu H
    Stat Med; 2017 Apr; 36(9):1476-1490. PubMed ID: 28070895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust joint modeling of longitudinal measurements and competing risks failure time data.
    Li N; Elashoff RM; Li G
    Biom J; 2009 Feb; 51(1):19-30. PubMed ID: 19197956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Copula Approach to Joint Modeling of Longitudinal Measurements and Survival Times Using Monte Carlo Expectation-Maximization with Application to AIDS Studies.
    Ganjali M; Baghfalaki T
    J Biopharm Stat; 2015; 25(5):1077-99. PubMed ID: 25372017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint analysis of longitudinal measurements and spatially clustered competing risks HIV/AIDS data.
    Momenyan S
    Stat Med; 2021 Dec; 40(28):6459-6477. PubMed ID: 34519089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.